Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference14 articles.
1. Pasquini MC, Zhu X Current uses and outcomes of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2015. http://www.cibmtr.org .
2. Storb R, Deeg HJ, Pepe M, Appelbaum F, Anasetti C, Beatty P, et al. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. Blood. 1989;73:1729–34.
3. Ruutu T, van Biezen A, Hertenstein B, Henseler A, Garderet L, Passweg J, et al. Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2012;47:1459–64.
4. Kino T, Hatanaka H, Hashimoto M, Nishiyama M, Goto T, Okuhara M, et al. FK506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physicochemical and biological characteristics. J Antibiot. 1987;40:1249.
5. Ratanatharathorn B, Nash RA, Przepiorka, Devine SM, Klein JL, Weisdorf D, et al. Phase III Study Comparing Methotrexate and Tacrolimus (Prograf, FK506) with Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis after HLA-Identical Sibling Bone Marrow Transplantation. Blood. 1998;92:2303–14.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献